Antitumour Effects of Streptococcal Lipoteichoic Acids on Meth A Fibrosarcoma
Author Information
Author(s): H. Usami, A. Yamamoto, W. Yamashita, Y. Sugawara, S. Hamada, T. Yamamoto, K. Kato, S. Kokeguchi, H. Ohokuni, S. Kotani
Primary Institution: Chugai Pharmaceutical Co., Ltd.
Hypothesis
The study aims to examine the antitumour effects of lipoteichoic acids (LTA) extracted from Streptococcus pyogenes in comparison with other streptococcal cellular components.
Conclusion
LTA significantly suppressed the growth of Meth A fibrosarcoma and induced tumour necrosis factor (TNF) in mice, indicating its potential as an antitumour agent.
Supporting Evidence
- LTA-treated mice had a mean survival time 2.8 times longer than non-treated mice.
- Four out of eight LTA-treated mice were tumour-free 34 days after inoculation.
- Only LTA significantly inhibited tumour growth compared to other streptococcal components.
Takeaway
This study found that a substance from bacteria called LTA can help fight a type of cancer in mice by making their bodies produce a special chemical that fights tumors.
Methodology
The study involved injecting different streptococcal components into mice with Meth A fibrosarcoma and measuring tumour growth and survival rates.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
BALB/c and CD-1 female mice, aged 6-8 weeks.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website